The ‘professional, experienced, talented and dedicated’ team at Arnon, Tadmor-Levy maintains its stellar reputation for handling the full gamut of issues across the sector, including matters concerning the secondary use of health data collaborations, material transfer arrangements, and manufacturing agreements. In Jerusalem, Barry Levenfeld regularly acts for both domestic and international life sciences companies in M&A, private equity, and licensing transactions; the ‘tremendous’ Daniel Green’s primary areas of focus are technology and licensing transactions within the medical device, pharma, and IT industries; and the ‘amazing’ Yoheved Novogroder Shoshan is well-versed in IP law, assisting global pharma entities and investors on in-licensing and R&D collaborations. Working out of the Tel Aviv office, Efrat Shapira-Orren is known for her exceptional experience in assisting private hospitals and medical centers on an array of regulatory issues. Miriam Friedmann is noted for deep expertise in licensing and privacy issues.

The diverse offering at FISCHER (FBC & Co.) is noted for its ‘vast experience and knowledge' of corporate transactions within the sector, in addition to handling a variety of data protection, corporate governance, and patent portfolio management. Raz Tepper jointly heads the practice alongside Eran Yaniv; Tepper represents both domestic and international biopharmaceutical and medical services clients, and Yaniv is particularly adept at handling cross-border corporate transactions within the medtech space. Shmulik Fried regularly advises funds on their investments into medtech companies within the digital health and medical device industries, and Warren Wienburg, known for his deep knowledge of corporate transactions, was promoted to partner in January 2023. Sharon Gazit and Judy Amidor joined the team from Goldfarb Gross Seligman & Co. in March 2023. Gazit contributes her longstanding expertise in assisting venture capital funds and startups with a broad range of commercial transactions, while Amidor specialists in M&A and licensing agreements within the biotech space.

Goldfarb Gross Seligman & Co.‘s broad practice handles a diverse range of matters, including class actions and tender processes. Practice head Hili Cohen maintains a technology focused practice, assisting a range of clients across the medical devices, digital health, and pharma industries with R&D and licensing related transactions, in addition to advising on clinical trials and joint ventures. Ofir Goldstein has exceptional knowledge of technology related licensing agreements, capital financings, and investment agreements on both a domestic and international scale, acting fur numerous start-ups and global life sciences companies. Roy Lieber, Tami Fishman Jutkowitz , Sharon Gazit , and Judy Amidor departed the practice in early 2023.

Neta Dorfman-Raviv and Zohar Yahalom jointly lead the ‘efficient, effective, knowledgeable and kind’ team at Herzog Fox & Neeman. The practice displays deep bench strength across a wide variety of areas, advising a varied client base of both state-owned and private hospitals and research institutions on the use of health data and hospital spin-offs. Yahalom is known for his expansive regulatory knowledge, regularly assisting companies in the pharma, biotech, and medical device spaces with reimbursement related matters, and generic competition, and Dorfman-Raviv primarily acts for hospitals, Israeli health maintenance organisations (HMO), and insurers in their interactions with government entities, including the Ministry of Health. Dan Sharot is well-versed in IP licensing issues, regularly advising on medical equipment purchasing, research collaboration, and patent licence agreements.

Horn & Co houses a ‘dedicated and effective’ practice, best known for handling the full spectrum of transactional issues, including asset purchase agreements and joint ventures, in addition to manufacturing, supply, and distribution agreements. Yuval Horn leads the team, and is known for his extensive expertise in handling multijurisdictional M&A, corporate reorganisations, and public offerings in the US, Europe, and Israel. Corporate finance specialist Keren Kanir represents both public and private companies, and investors on a vast array of issues, including the establishment of funds, data licensing agreements, and private investment rounds led by angel investors and venture capital funds.

Lipa Meir & Co maintains its market-leading reputation for advising cannabis start-ups, whilst handling the full range of contentious and non-contentious issues across the sector. The team regularly acts in class actions and advises on IP licensing issues, fund raisings, and the secondary use of healthcare data. Practice head Gary Copelovitz assists domestic and global healthcare clients with a wide variety of corporate issues and M&A, whilst Meir Elbaum is known for advising public and private hospitals and clinics on healthcare insurance programmes, tenders, and their agreements with importers and suppliers. Dispute resolution expert Isaac Anidjer represents entrepreneurs in procedural matters concerning the acquisition of licenses, and negotiations with healthcare service providers. Anidjer is also noted for his broad knowledge of the operation of geriatric medical centres.

Co-led by Tal Band, Dovev Apel, and Ran Vogel, the team at S. Horowitz & Co exhibits deep expertise in the full spectrum of issues concerning product liability cases, IP, and sector specific regulation. The team is noted for handling the patent aspects of corporate transactions, particularly in relation to the financing of innovation focused companies and patent licences. Band is well-versed in the full range of IP issues, including patent, trade mark, and copyright disputes, regularly appearing before the Israeli Patents and Trademarks Office. Apel is particularly adept at handling regulatory issues concerning medical devices, e-health, and pharma, with emphasis on class actions and cases concerning the advertising and distribution of medical products, areas in which Yair Ziv also has a great deal of expertise.

Agmon with Tulchinsky Law Firm's diverse offering serves a varied client base of venture capital funds looking to invest in start-ups within the sector, in addition to handling data protection and privacy issues. Ehud Arad, Osnat Sarusi Firstater, and Uri Barak co-lead the practice. Arad’s primary areas of focus include multijurisdictional transactions, having acted for a large number of healthcare start-ups; Firstater leads the firm’s technology practice, primarily advising medtech start-ups on joint ventures and M&A; and Barak is known for his extensive commercial experience, having handled a broad range of series financings and management buyouts. Alon Tabak-Aviram is known for assisting biotech and pharma companies on the negotiation of R&D and manufacturing agreements.

Praised by clients for its ‘wide range of expertise', Gornitzky & Co. acts for its varied client base of medical equipment manufacturers and distributors, and pharma companies. The team is jointly led by Assaf Harel, Itamar Mei-Zahav, Netta Shaked-Stadler, and Shy Baranov. Harel is well-versed in the full range of data privacy and cyber-security issues, whilst advising on internal anti-corruption policies. Mei-Zahav is known for his extensive corporate expertise, assisting a number of healthcare clients with IPOS and strategic collaborations. Corporate law specialist Rebecca Genis is particularly adept at handling the drafting of medical data processing agreements within the medical device industry.

Rated by clients as ‘one of the top, if not the top' IP firms in Israel, Liad Whatstein & Co. Law Office is well-known for handling the full spectrum of contentious and non-contentious patent-related issues across the life sciences and healthcare sector. The ‘technically excellent, diligent and dedicated' Liad ‎ Whatstein and Amira Mangelus jointly lead the team. Primarily acting for global pharma companies, Whatstein is an IP litigator who has deep knowledge of healthcare regulatory issues and blockbuster drug lifecycle management. Mangelus is an expert in patent litigation, handling infringement actions and patent application prosecutions. Oren Weiner has exceptional expertise in patent term extensions, regularly appearing before the Israeli Patent offices and district courts.

M. Firon & Co Advocates and Notaries' ‘multifaceted, attentive and highly experienced' practice handles a broad array of matters, including licensing agreements and investment rounds, investment transactions, and injunction negotiations. Hailed by clients as ‘the most eminent healthcare lawyer in the country', practice co-head Baruch Shugol is known for his deep expertise in the biotech and pharma industries, regularly advising clients on R&D and antitrust issues. The ‘brilliant, conscientious, and reliable' co-head Sivan Narkiss acts for private hospitals, medical device distributors, and biotech start-ups in a vast range of regulatory mandates involving clinical trials and post marketing studies.

The broad practice at Pearl Cohen Zedek Latzer Baratz acts for a varied client base of tech transfer companies, healthcare start-ups, and major pharma corporations. All co-heading the practice, Yael Baratz leads on the corporate and licensing side of the practice, handling cross-border M&A and non-dilutive financing issues; Hili Rashkovan regularly assists clients with joint development agreements and clinical trials; and Baruch Avrahami is well-known for advising hospitals and healthcare companies. Dividing their time between Tel Aviv and New York, practice co-head Mark Cohen's primary areas of focus are pharma and medical device related patent prosecutions, and co-head Zeev Pearl is noted for his longstanding expertise in IP portfolio development and licensing disputes.

The team at Amit, Pollak, Matalon & Co. Advocates and Notary regularly assists with equity investments and data privacy compliance mandates. Practice co-head Ian Rostowsky is particularly adept at handling fund formation and M&A-related issues within the sector, while co-head Yoav Etzyon primarily acts for start-ups and emerging companies within the healthcare and life sciences arena. Assaf Baruch’s main areas of focus are commercial transactions within the tech sector, having advised a number of clients on a variety of commercial transactions, and Stephen Barak Rozen is well-versed in the formation of tech incubators.

Praised for its ‘very satisfying’ results in a wide variety of matters, including manufacturing and supply agreements, healthcare specific regulatory issues, and tenders, Barnea Jaffa Lande & Co. assists a range of clients, from digital health start-ups, to surrogacy companies. ‘Incredibly smart’ practice head Michael Barnea is noted for his longstanding expertise in advising medical device and healthtech companies, R&D centers, and private equity funds on a vast array of IP and commercial transactions. Ken Shaked regularly assists both public and private corporations with IP due diligence issues, and the drafting and negotiation of technology transfer and licensing agreements.

Jointly led by Haim Gueta, Boaz Mizrahi, and Ron Peleg, the Ramat-Gan based team at Meitar Law Offices is well-equipped to handle the full range of transactional issues, including funding rounds, supply agreements, and investments. Mizrahi is particularly adept at handling licensing deals and collaborations, advising a variety of academic institutes and hospitals. Adi Blumenthal Yaari has a great deal of knowledge surrounding technology and IP, and is well-versed in matters concerning dealings with the Israeli Health Ministry.

Shibolet & Co.’s varied offering assists a broad client list, consisting of domestic incubators, academic institutions, and investment companies. Ofer Ben-Yehuda leads the team alongside Einat Weidberg. Ben-Yehuda is noted for his expansive transactional expertise, regularly assisting clients with venture capital financings, private placements, and strategic alliances. Weidberg regularly acts for both Israeli and overseas clients in mandates concerning cross-border M&A, public offerings, and corporate debt finance. Regulatory and crisis management specialist Amos Bentzur advises HMOs and both public and private healthcare systems on the full range of operational matters.